Navigation Links
Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting

a poster session beginning on Sunday, May 20, 2007 at 8:00 a.m. EDT.

Dr. David Standring, Senior Vice President, Biology at Idenix Pharmaceuticals, will present "Resistance Determination in Patients Experiencing Virologic Breakthrough Following Telbivudine or Lamivudine Therapy in the International GLOBE Trial" in a poster session beginning on Sunday, May 20, 2007 at 8:00 a.m. EDT.

Important Information About TYZEKA(R) (telbivudine)

TYZEKA is indicated for the treatment of chronic hepatitis B in adult patients with evidence of viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. This indication is based on virologic, serologic, biochemical and histologic responses after one year of treatment in nucleoside-treatment-naive adult patients with HBeAg-positive and HbeAg-negative chronic hepatitis B with compensated liver disease. For full prescribing information please visit http://www.tyzeka.com .

    Important Safety Information about TYZEKA (telbivudine)


    -- Lactic acidosis and severe hepatomegaly with steatosis, including fatal

       cases, have been reported with the use of nucleoside analogues alone or

       in combination with antiretrovirals. Severe acute exacerbations of

       hepatitis B have been reported in patients who have discontinued anti-

       hepatitis B therapy, including TYZEKA. Hepatic function should be

       monitored closely with both clinical and laboratory follow-up for at

       least several months in patients who discontinue anti-hepatitis B

       therapy. If appropriate, resumption of antihepatitis B therapy may be

       warranted.

    -- Cases of myopathy have been reported with TYZEKA use several weeks to

       months after starting therapy. Myopathy has also been reported with

       some other drugs in this class. Physicians considering concomitan
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Idenix Reports Results from Two Phase IIb Studies of the Combination of Valopicitabine and Pegylated Interferon in Hepatitis C Genotype-1 Patients at the 42nd Annual Meeting of the European Association for the Study of the Liver
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:7/29/2014)... 2014  The Healthcare Analytics Summit 2014 ... Salt Lake City , Sept. 24-25 has ... healthcare organizations in the U.S. and beyond.  HAS ,14, ... conference devoted to providing immersive learning experiences on ... both accountable care initiatives and population health managemen ...
(Date:7/29/2014)... IRVING, Texas , July 29, 2014 /PRNewswire/ ... three new web-based applications with breakthrough interactive features ... and workflows for members of Children,s Hospital Association.  ... under the Novation Optimize Solutions umbrella – Value ... of how Novation helps organizations address the most ...
(Date:7/29/2014)... July 29, 2014   Abide Therapeutics ... to its board of directors. Thornberry was ... and Endocrinology for Merck & Co. Inc., where ... pipeline management in diabetes, osteoporosis, fertility and contraception. ... the program that resulted in the discovery of ...
Breaking Medicine Technology:Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 2Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 3Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 4Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 5Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 2Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 3Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 4Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 5Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 3
(Date:7/29/2014)... 29, 2014 Gummy smile surgeon , ... dark gums treatments that can enhance and perfect gummy smiles ... appearance that displays the teeth to their best advantage. Some ... or have gums that are dark or discolored. Patients with ... self-conscious about their smiles or experience a high level of ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 On July 28, ... McElwee is a member of the band Fowler’s Mustache ... as how the band came up with their name. At ... most interesting topics with every band is how they formed ... story is unique so what is the Fowler’s Mustache story?” ...
(Date:7/29/2014)... HealthDay Reporter , MONDAY, July 28, 2014 (HealthDay News) -- ... don,t run, according to new research. But, the best ... reap this benefit even if you run at slow speeds for ... may not need to run a lot to get health benefits," ... Iowa State University. "I hope this study can motivate more people ...
(Date:7/29/2014)... stem-cell discovery might one day lead to a more streamlined ... used in the development of replacement tissue for failing body ... findings in the current edition of Cell . , ... cells back to an embryonic state in which they again ... , The efficiency of this process may soon increase thanks ...
(Date:7/29/2014)... According to an article in the ... from a 52 year old woman in India. The surgery ... reportedly had no idea that she had such a large ... breathlessness for years, but did not connect it to a ... discovered the massive uterine fibroid after Latha was admitted for ...
Breaking Medicine News(10 mins):Health News:Gummy Smile Surgeon, Dr. Alex Farnoosh, Now Offers Procedures to Improve Gummy Smiles and Dark Gums 2Health News:My Positive Perspective Broadcasts Episode with Thomas McElwee of the Band Fowler’s Mustache 2Health News:Running Could Add 3 Years to Your Lifespan 2Health News:Running Could Add 3 Years to Your Lifespan 3Health News:Stem cell advance may increase efficiency of tissue regeneration 2Health News:Stem cell advance may increase efficiency of tissue regeneration 3Health News:World’s Largest Uterine Fibroid Removed from Patient 2Health News:World’s Largest Uterine Fibroid Removed from Patient 3
... More than 125 leaders,from throughout the state ... to support a multi-year, statewide campaign to Make ... launched by Nemours Health,and Prevention Services (NHPS), will ... professionals, parents, and other leaders to,improve the motivation, ...
... Oct. 1 The Coalition to,Protect Florida,s Drivers ... thanked him for expanding the call of this ... expired at midnight,today. Saying that Personal Injury ... of Florida" and that $10,000 in PIP coverage,provides ...
... Bally Total Fitness announced,that it has successfully ... company,just over two months after filing for bankruptcy ... by Harbinger Capital Partners,Master Fund I, Ltd. and ... effective today. Harbinger invested approximately $233.6 million ...
... WASHINGTON, Oct. 1 The following is being,issued by ... Emmanuel Cleaver, D-Missouri Congresswoman Heather Wilson, R- New Mexico ... author of God,s Politics, Others Participating: ... national Catholic Social Justice Lobby Father ...
... public entities in the addiction treatment field announced the ... Now (ACTION) Campaign for the improvement of addiction treatment ... to addiction treatment for individuals in need and to ... launched during National Recovery Month in September, has a ...
... Oct. 1 Air Methods Corporation,(Nasdaq: AIRM ), ... today that the Company has completed its acquisition of,100% ... (parent,company of CJ Systems Aviation Group, Inc., or "CJ") ... today at 12:01 a.m. The final cash purchase ...
Cached Medicine News:Health News:More than 125 State Leaders - Including Governor, Lt. Governor, and Congressional Delegation - Endorse Campaign to Make Delaware's Kids the Healthiest in the Nation 2Health News:More than 125 State Leaders - Including Governor, Lt. Governor, and Congressional Delegation - Endorse Campaign to Make Delaware's Kids the Healthiest in the Nation 3Health News:Coalition to Protect Florida's Drivers Applauds Governor Crist for Adding PIP to Special Session 2Health News:Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds 2Health News:Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds 3Health News:Leaders in addiction treatment announce national 'ACTION' campaign 2Health News:Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc. 2
... 2 gel holder cassettes, 4 fiber pads, ... buffer chamber, lid with cables, and instructions. ... of Bio-Rad's modular mini electrophoresis system (see ... of mini gels. Its modular electrode assembly ...
... 200 power supply. Flexibility ... Quantitative Transfers. Native Enzyme, ... Faster, Higher-Efficiency Transfers via ... Transfers with Movable Electrodes. ...
... gel holder cassettes, cell with ... pads, blot absorbent paper (15 ... transfer cell, used with the ... efficient, high-intensity electrophoretic transfers. The ...
... for running Criterion precast gels and ... blotter fit for use with the ... the Criterion blotter combines excellent blotting ... Trans-Blot system and the ease-of-use of ...
Medicine Products: